NCT01543880已完成不适用
Non-interventional Study of Safety and Efficacy of Long-term Somatropin Treatment in Adults
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 752
- 主要终点
- Number of adverse events
研究概览
简要总结
This study is conducted in Europe. The aim of the study is to evaluate safety and efficacy in adults treated with somatropin (Norditropin®).
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 20 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •In need of somatropin or current user
排除标准
- 未提供
研究组 & 干预措施
Users of somatropin
干预措施: somatropin (Drug)
结局指标
主要结局
Number of adverse events
时间窗: Up to 10 years
次要结局
- BMI (Body Mass Index)(Up to 10 years)
- IGF-I (Insulin-Like Growth Factor I)(Up to 10 years)
- HbA1c change(Up to 10 years)
研究者
相似试验
已完成
不适用
Safety and Efficacy of Long-term Somatropin Treatment in ChildrenGrowth Hormone DisorderFoetal Growth ProblemGenetic DisorderSmall for Gestational AgeGrowth DisorderTurner SyndromeIdiopathic Short StatureGrowth Hormone Deficiency in ChildrenNCT01543867Novo Nordisk A/S5,442
已完成
不适用
Observational Safety Study in Subjects With Type 2 Diabetes Mellitus Starting or Switching to Biphasic Insulin Aspart 30 TreatmentDiabetesDiabetes Mellitus, Type 2NCT01548235Novo Nordisk A/S423
已完成
不适用
Safety of Treatment Initiation With Biphasic Insulin Aspart 30 in Hospitalised Patients With Type 2 DiabetesDiabetesDiabetes Mellitus, Type 2NCT01565733Novo Nordisk A/S2,223
已完成
不适用
Non-interventional Study of Ectoin Nasal Douche (END01) in Patients With Acute Viral RhinosinusitisAcute RhinosinusitisNCT03480100Bitop AG120
尚未招募
4 期
To evaluate the Safety and Efficacy of ACELABS SerumCTRI/2024/02/063322Bright Diva Pte. Ltd.